dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: Association with survival and response to 5-fluorouracil in colorectal cancer

Cancer Research

Volumn 60, Issue 13, 2000, Pages 3493-3503

  Ladner, Robert D ^a   Lynch, Frank J ^b   Groshen, Susan ^c   Xiong, Yi Ping ^c   Sherrod, Andrew ^c   Caradonna, Salvatore J ^a   Stoehlmacher, Jan ^c   Lenz, Heinz Josef ^c  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b QualTek Molecular Laboratories   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CELL CYCLE; CELL KILLING; CELL PROLIFERATION; CLINICAL ARTICLE; COLORECTAL CANCER; CYTOTOXICITY; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; CELL SURVIVAL; CELLS, CULTURED; COLON; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; ETHNIC GROUPS; FEMALE; FLUOROURACIL; HELA CELLS; HUMANS; INTESTINAL MUCOSA; ISOENZYMES; LYMPHOCYTES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PYROPHOSPHATASES; REFERENCE VALUES; TUMOR CELLS, CULTURED; UNITED STATES;

EID: 0034234872     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Moertel, C. G. Chemotherapy for colorectal cancer. N. Engl. J. Med., 330: 1136-1143, 1994.
2. Grem, J. L. 5-Fluorouracil plus leucovorin in cancer therapy. In: V. T. De Vita, Jr., S. Hellman, and S. A. Rosenberg (eds.), Principals and Practice of Oncology Update Series, 2(7) July. Philadelphia: J. B. Lippincott, 1988.
3. Cohen, S. S. On the nature of thymineless death. Ann. NY Acad. Sci., 106: 292-301, 1971.
4. Aherne, G. W., and Browne, S. The role of uracil misincorporation in thymineless death. In: A. L. Jackman (ed.), Anticancer Drug Development Guide: Antifolate Drugs in Cancer Therapy, pp. 409-421. Totowa, NJ: Humana Press, Inc., 1999.
5. Lindahl, T. Instability and decay of the primary structure of DNA. Nature (Lond.), 362: 709-715, 1993.
6. Bertani, E., Häggmark, A., and Reichard, P. Enzymatic synthesis of deoxyribonucleotides. II. Formation and intraconversion of deoxyuridine phosphates. J. Biol. Chem., 238: 3407-3413, 1963.
7. Lindahl, T. DNA repair enzymes. Annu. Rev. Biochem., 51: 61-87, 1982.
8. El-Hajj, H. H., Zhang, H., and Weiss, B. Lethality of a dut (deoxyuridine triphosphatase) mutation in Escherichia coli. J. Bacteriol., 170: 1069-1075, 1988.
9. Gadsden, M. H., McIntosh, E. M., Game, J. C., Wilson, P. J., and Haynes, R. H. dUTP pyrophosphatase is an essential enzyme in Saccharomyces cerevisiae. EMBO J., 12: 4425-4431, 1993.
10. Goulian, M., Bleile, B., and Teng, B. Y. The effect of methotrexate on dUTP levels in animal cells. J. Biol. Chem.. 255: 10630-10637, 1980.
11. Goulian, M., Bleile, B., and Teng, B. Y. Methotrexate-induced misincorporation of uracil into DNA. Proc. Natl. Acad. Sci. USA, 77: 1956-1960, 1980.
12. Beck, W. R., Wright, G. E., Nusbaum, N. J., Chang, J. D., and Isselbacher, E. M. Enhancement of methotrexate cytotoxicity by uracil analogues that inhibit deoxyuridine triphosphate nucleotidohydrolase (dUTPase) activity. Adv. Exp. Med. Biol., 195 (Part B): 97-104, 1986.
13. Curtin, N. J., Harris, A. L., and Aherne, G. W. Mechanism of cell death following thymidylate synthase inhibition: 2′-deoxyuridine-5′-triphosphate accumulation, DNA damage and growth inhibition following exposure to CB3717 and dipyridamole. Cancer Res., 51: 2346-2352, 1991.
14. Ingraham, H. A., Dickey, L., and Goulian, M. DNA fragmentation and cytotoxicity from increased cellular deoxyuridylate. Biochemistry, 25: 3225-3230, 1986.
15. Sedwick, W. D., Kutler, M., and Brown, O. E. Antifolate-induced misincorporation of deoxyuridine monophosphate into DNA: inhibition of high molecular weight DNA synthesis in human lymphoblastoid cells. Proc. Natl. Acad. Sci. USA, 78: 917-921, 1981.
16. Canman, C. E., Radany, E. H., Parsels, L. A., Davis M. A., Lawrence, T. S., and Maybaum, J. Induction of resistance to fluorodeoxyuridine cytotoxicity and DNA damage in human tumor cells by expression of Escherichia coli deoxyuridine triphosphatase. Cancer Res., 54: 2296-2298, 1994.
17. Parsels, L. A., Parcels, J. D., Wagner, L. M., Lonely, T. L., Radany, E. H., and Maybaum, J. Mechanism and pharmacological specificity of dUTPase-mediated protection from DNA damage and cytotoxicity in human tumor cells. Cancer Chemother. Pharmacol., 42: 357-362, 1998.
18. Conley, B. A., Kaplan, R. S., and Arbuck, S. G. National Cancer Institute Clinical Trials Program in Colorectal Cancer. Cancer Chemother Pharmacol., 42 (Suppl.): S75-S79, 1998.
19. Johnston, P. G., Lenz. H-J., Leichman, C. G., Danenberg. K. D., Allegra, C. J., Danenherg, P. V., and Leichman, L. Thymidylate synthase protein and gene expression predicts for response to 5-fluorouracil. leucovorin in patients with colorectal and gastric cancer. Cancer Res., 55: 1407-1412, 1995.
20. Lenz, H-J., Leichman, C. G., Danenberg, K. D., Danenberg, P. V., Groshen, S., Cohen, H., Laine, L., Crookes, P., Silberman, H., Baranda, J., Garcia, Y., Li, J., and Leichman, L. Thymidylate synthase expression in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. J. Clin. Oncol., 14: 176-182, 1996.
21. Leichman, C. G., Lenz, H-J., Leichman, L., Danenberg, K. D., Baranda, J., Groshen, S., Boswell, W., and Danenberg, P. V. Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted infusional 5-fluorouracil and weekly leucovorin. J. Clin. Oncol., 15: 3223-3229, 1997.
22. Lenz, H-J., Danenberg, K. D., Leichman, C. G., Florentine, B., Johnston, P. G., Groshen, S., Zhou, L., Xiong, Y. P., Danenberg, P. V., and Leichman, L. P. p53 and thymidylate synthase expression in untreated stage II colon cancer: association with recurrence, survival, and site. Clin. Cancer Res., 4: 1227-1234, 1998.
23. Fox, S. B., Engels, K., Comley, M., Whitehouse, R. M., Turley, H., Gatter, K. C., and Harris, A. L. Relationship of elevated thymidine phosphorylase in node positive breast carcinomas to the effects of adjuvant CMF. Ann. Oncol., 8: 271-275, 1997.
24. Lirette, R., and Caradonna, S. Inhibition of phosphorylation of cellular dUTP nucleotidohydrolase as a consequence of herpes simplex virus infection. J. Cell. Biochem., 43: 339-353, 1990.
25. Ladner, R. D., McNulty, D. E., Carr, S. A., Roberts, G. D., and Caradonna, S. J. Characterization of distinct nuclear and mitochondrial forms of human dUTPase. J. Biol. Chem., 271: 7745-7751, 1996.
26. Muller, S. J., and Caradonna, S. Cell cycle regulation of a human cyclin-like gene encoding uracil-DNA glycosylase. J. Biol. Chem., 268: 1310-1319, 1993.
27. Taylor, C. R., Shi, S. R., Chen, C., Yang, C., and Cote R. J. Comparative study of antigen retrieval heating methods: microwave, microwave and pressure cooker, autoclave, and steamer. Biotech. Histochem., 71: 263-270, 1996.
28. Lenz, H. J., Hayashi, K., Salonga, D., Danenberg, K. D., Danenberg, P. V., Metzger, R., Banerjee, D., Bertino, J. R., Groshen, S., Leichman, L. P., and Leichman, C. G. p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survival. Clin. Cancer Res., 4: 1243-1250, 1998.
29. Kaplan, E. L., Meier, P. Nonparametric estimation form incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
30. Miller, R. G., Jr. Survival Analysis, pp. 114-118. New York: John Wiley and Sons, 1981.
31. Ladner, R. D., Carr, S. A., Huddleston, M. J., McNulty, D. E., and Caradonna, S. J. Identification of a consensus cyclin dependent kinase phosphorylation site unique to the nuclear form of human dUTPase. J. Biol. Chem., 271: 7752-7757, 1996.
32. Ladner, R. D., and Caradonna, S. J. The human dUTPase gene encodes both nuclear and mitochondrial isoforms: differential expression of the isoforms and characterization of a cDNA encoding the mitochondrial species. J. Biol. Chem., 272: 19072-19080, 1997.
33. Clayton, D. A. Replication and transcription of vertebrate mitochondrial DNA. Annu. Rev. Cell Biol., 7: 453-478, 1991.
34. Brown, D. C., and Gatter, K. C. Monoclonal antibody Ki-67: its use in histopathology. Histopathology, 17: 489-503, 1990.
35. Epstein, A. L., and Clevenger, C. V. Identification of nuclear antigens in human cells by immunofluorescence, immunoelectron microscopy, and immunobiochemical methods using monoclonal antibodies. In: I. Beckhor (ed.), Progress in Nonhistone Protein Research, Vol. 1, pp. 117-137. Boca Raton, FL: CRC Press, 1985.
36. Ogawa, M., Maeda, K., Onoda, N., Chumg, Y. S., and Sowa, M. Loss of p21WAF1/ CIP1 expression correlates with disease progression in gastric carcinoma. Br. J. Cancer, 75: 1617-1620, 1997.
37. Stein, J. P., Ginsberg, D. A., Grossfeld, G. D., Chatterjee, S. J., Esrig, D., Dickenson, M. G., Groshen, S., Taylor, C. R., Jones, P. A., Skinner, D. G., and Cote, R. J. Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer. J. Natl. Cancer Inst., 90: 1072-1079, 1998.
38. Kirihara, Y., Yamamoto, W., Toge, T., and Nishiyama, M. Dihydropyrimidine dehydrogenase, multidrug resistance-associated protein, and thymidylate synthase gene expression levels can predict 5-fluorouracil resistance in human gastrointestinal cancer cells. Int. J. Oncol., 14: 551-556, 1999.
39. Etienne, M. C., Pivot, X., Formento, J. L., Bensadoun, R. J., Formento, P., Dassonville, O., Francoual, M., Poissonnet, G., Fontana, X., Schneider, M., Demard, F., and Milano, G. A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict outcome in head and neck cancer patients receiving 5-fluorouracil. Br. J. Cancer, 70: 1864-1869, 1999.
40. Fleischmann, J., Kremmer, E., Muller, S., Sommer, P., Kirchner, T., Niedobitek, G., and Grasser, F. A. Expression of deoxyuridine triphosphatase (dUTPase) in colorectal tumours. Int. J. Cancer, 84: 614-617, 1999.
41. McIntosh, E. M., and Haynes R. H. dUTP pyrophosphatase as a potential target for chemotherapeutic drug development. Acta Biochim. Pol., 44: 159-171, 1997.
42. Hoar, D. I., and Dimnik, L. S. Induction of mitochondrial mutations in human cells by methotrexate. In: F. J. de Serres (ed.), Genetic Consequences of Nucleotide Pool Imbalance, pp. 265-282. New York: Plenum Publishing Corp., 1985.
43. Barclay, B. J., and Little, J. G. Genetic damage during thymidylate starvation in Saccharomyces cerevisiae. Mol. Gen. Genet., 160: 33-40, 1978.
44. Wallace, D. C., Bunn, C. L., and Eisenstadt, J. M. Cytoplasmic transfer of chloramphenicol resistance in human tissue culture cells. J. Cell Biol., 67: 174-199, 1975.
45. Wurtz, E. A., Sears, B. B., Rabert, D. K., Shepard, H. S., Gillham, N. W., and Boytnton, J. E. A specific increase in chlomplast gene mutations following growth of Chlamydomonas in 5-fluorodeoxyuridine. Mol. Gen. Genet., 170: 235-242, 1979.